These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
96 related items for PubMed ID: 2557173
1. Effects of atrial natriuretic peptide on the coronary arterial vasculature in humans. Chu A, Morris KG, Kuehl WD, Cusma J, Navetta F, Cobb FR. Circulation; 1989 Dec; 80(6):1627-35. PubMed ID: 2557173 [Abstract] [Full Text] [Related]
2. Preferential proximal coronary dilation by activators of guanylate cyclase in awake dogs. Chu A, Murray JJ, Lin CC, Russell M, Hagen PO, Cobb FR. Am J Physiol; 1990 Aug; 259(2 Pt 2):H340-5. PubMed ID: 1974738 [Abstract] [Full Text] [Related]
4. Effects of synthetic human atrial natriuretic peptide on the human coronary circulation in subjects with normal coronary arteries. Egashira K, Inou T, Imaizumi T, Tomoike H, Takeshita A. Jpn Circ J; 1991 Nov; 55(11):1050-6. PubMed ID: 1836240 [Abstract] [Full Text] [Related]
5. Effect of atrial natriuretic factor on transmural myocardial blood flow distribution in the dog. Bauman RP, Rembert JC, Himmelstein SI, Klotman PE, Greenfield JC. Circulation; 1987 Sep; 76(3):705-9. PubMed ID: 2957114 [Abstract] [Full Text] [Related]
6. Effects of intravenous atrial natriuretic peptide and nitroglycerin on coronary vasodilation and flow velocity determined using 3 T magnetic resonance imaging in patients with nonischemic heart failure. Ehara S, Nakamura Y, Matsumoto K, Hasegawa T, Shimada K, Takagi M, Hanatani A, Izumi Y, Terashima M, Yoshiyama M. Heart Vessels; 2013 Sep; 28(5):596-605. PubMed ID: 23014927 [Abstract] [Full Text] [Related]
7. Supersensitive dilator response to nitroglycerin but not to atrial natriuretic peptide in spastic coronary arteries in coronary spastic angina. Kugiyama K, Ohgushi M, Sugiyama S, Motoyama T, Kawano H, Hirashima O, Yasue H. Am J Cardiol; 1997 Mar 01; 79(5):606-10. PubMed ID: 9068517 [Abstract] [Full Text] [Related]
8. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure]. Kobusiak-Prokopowicz M, Swidnicka-Szuszkowska B, Mysiak A. Pol Arch Med Wewn; 2001 Jun 01; 105(6):475-82. PubMed ID: 11865578 [Abstract] [Full Text] [Related]
9. In vivo vasodilatory action of atrial natriuretic peptides in canine coronary circulation. Liu Q, Nakae I, Tsutamoto T, Takaoka A, Kinoshita M. Jpn Circ J; 1996 May 01; 60(5):300-10. PubMed ID: 8803724 [Abstract] [Full Text] [Related]
10. Atrial natriuretic peptide attenuates pacing-induced myocardial ischemia during general anesthesia in patients with coronary artery disease. Valsson F, Lundin S, Kirnö K, Hedner T, Houltz E, Saito Y, Ricksten SE. Anesth Analg; 1999 Feb 01; 88(2):279-85. PubMed ID: 9972741 [Abstract] [Full Text] [Related]
11. Sustained dilatation of large coronary artery by alpha-human atrial natriuretic peptide in conscious dogs: a comparison with nitroglycerin. Adachi H, Tomoike H, Nishijima H, Egashira S, Nakamura M. Eur J Pharmacol; 1989 Feb 28; 161(2-3):189-96. PubMed ID: 2524391 [Abstract] [Full Text] [Related]
12. Effects of atrial natriuretic peptide in the canine coronary circulation. Bache RJ, Dai XZ, Schwartz JS, Chen DG. Circ Res; 1988 Jan 28; 62(1):178-83. PubMed ID: 2961478 [Abstract] [Full Text] [Related]
13. Effects of brain (B-type) natriuretic peptide on coronary artery diameter and coronary hemodynamic variables in humans: comparison with effects on systemic hemodynamic variables. Okumura K, Yasue H, Fujii H, Kugiyama K, Matsuyama K, Yoshimura M, Jougasaki M, Kikuta K, Kato H, Tanaka H. J Am Coll Cardiol; 1995 Feb 28; 25(2):342-8. PubMed ID: 7829786 [Abstract] [Full Text] [Related]
14. Vasorelaxing effects of atrial and brain natriuretic peptides on coronary circulation in heart failure. Matsumoto T, Wada A, Tsutamoto T, Omura T, Yokohama H, Ohnishi M, Nakae I, Takahashi M, Kinoshita M. Am J Physiol; 1999 Jun 28; 276(6):H1935-42. PubMed ID: 10362673 [Abstract] [Full Text] [Related]
15. Atrial natriuretic peptide decreases hepatic and cardiac blood content, but increases intestinal blood content in supine humans. Peters J, Neuser D, Schaden W, Arndt JO. Basic Res Cardiol; 1992 Jun 28; 87(3):250-62. PubMed ID: 1325772 [Abstract] [Full Text] [Related]
16. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels. Nakajima K, Onishi K, Dohi K, Tanabe M, Kurita T, Yamanaka T, Ito M, Isaka N, Nobori T, Nakano T. Int J Cardiol; 2005 Oct 10; 104(3):332-7. PubMed ID: 16186065 [Abstract] [Full Text] [Related]
17. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor. Hirata Y, Matsuoka H, Suzuki E, Hayakawa H, Sugimoto T, Matsuda Y, Morishita Y, Kangawa K, Minamino N, Matsuo H. Circulation; 1993 Feb 10; 87(2):554-61. PubMed ID: 8381060 [Abstract] [Full Text] [Related]
18. Attenuated forearm vasodilative response to intra-arterial atrial natriuretic peptide in patients with heart failure. Hirooka Y, Takeshita A, Imaizumi T, Suzuki S, Yoshida M, Ando S, Nakamura M. Circulation; 1990 Jul 10; 82(1):147-53. PubMed ID: 2163779 [Abstract] [Full Text] [Related]
19. Improvement in exercise-induced left ventricular dysfunction by infusion of alpha-human atrial natriuretic peptide in coronary artery disease. Ukai M, Nishinaka Y, Sobue T, Miyahara T, Yokota M. Am J Cardiol; 1995 Mar 01; 75(7):449-54. PubMed ID: 7863987 [Abstract] [Full Text] [Related]
20. Beneficial effects of atrial natriuretic peptide on exercise-induced myocardial ischemia in patients with stable effort angina pectoris. Lai CP, Egashira K, Tashiro H, Narabayashi H, Koyanagi S, Imaizumi T, Takeshita A. Circulation; 1993 Jan 01; 87(1):144-51. PubMed ID: 8419001 [Abstract] [Full Text] [Related] Page: [Next] [New Search]